NA

Nupurben Ambalal Patel

Active Director Director DIN 10185559
DIN 10185559 First appointment May 2023 Primary industry Paper
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Nupurben Ambalal Patel

Data last updated:

Nupurben Ambalal Patel is a Director at Lemonkure Healthcare Private Limited (since 2023). The company operates in Paper.

DIN 10185559
Primary Designation Director
Industry Paper
First Appointment 31 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lemonkure Healthcare Private Limited U21001GJ2023PTC141720
Director31 May 20232023Active

Board colleagues of Nupurben Ambalal Patel

Directorship timeline

Open interactive timeline →
Lemonkure Healthcare Private Limited
Premium access

Shareholding and investment profile for Nupurben Ambalal Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nupurben Ambalal Patel

Nupurben Ambalal Patel currently holds 1 directorship: Lemonkure Healthcare Private Limited (Director, since 31 May 2023).

Nupurben Ambalal Patel was first appointed on 31 May 2023 as Director at Lemonkure Healthcare Private Limited.

The current boards of Nupurben Ambalal Patel's companies include Alpaben Amishkumar Makadia (Lemonkure Healthcare Private Limited), Hiren Jayantibhai Patel (Lemonkure Healthcare Private Limited), Kunal Patel (Lemonkure Healthcare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available